Jessica Maitland
Education
M.Sc., public health, McGill University; B.Sc., health studies and environmental sciences, University of Toronto
Summary of Experience
Ms. Maitland specializes in epidemiology and health economics and outcomes research (HEOR). Her experience includes using various data sources, such as health insurance claims, data abstracted from patient medical charts, and national patient survey data, to retrospectively assess treatment patterns, burden of illness, and real-world safety and effectiveness of treatments. Ms. Maitland has conducted research in multiple therapeutic areas, including psychiatry (major depressive disorder, post-traumatic stress disorder, attention-deficit/hyperactivity disorder), oncology, and hepatology. Her research has been presented at conferences, including the International Society for Pharmacoeconomics and Outcomes Research, the Academy of Managed Care Pharmacy, and the American Association for the Study of Liver Diseases, and has been published in peer-reviewed journals such as The Journal of Clinical Psychiatry, BMC Psychiatry, and Current Medical Research and Opinion.
- 
                                                        Patient journey of civilian adults diagnosed with posttraumatic stress disorder—A chart review studyCurrent Medical Research and Opinion, 2024 
 2024Davis LL, Urganus A, Gagnon-Sanschagrin P, Maitland J, Bedard J, Bellefleur R, Cloutier M, Guérin A, Aggarwal J 
- 
                                                        Treatment Patterns among Patients with Attention-Deficit/Hyperactivity Disorder and Comorbid Anxiety and/or Depression in the United States: A Retrospective Claims AnalysisAdvances in Therapy, 2023 
 2023Schein J, Childress A, Gagnon-Sanschagrin P, Maitland J, Bedard J, Cloutier M, Guérin A 
- 
                                                        The Economic Burden of Adults with Major Depressive Disorder in the United States (2019)Advances in Therapy, 2023 
 2023Greenberg P, Chitnis A, Louie D, Suthoff E, Chen SY, Maitland J, Gagnon-Sanschagrin P, Fournier AA, Kessler RC 
- 
                                                        Patient journey before and after a formal post-traumatic stress disorder diagnosis in adults in the United States - a retrospective claims studyCurrent Medical Research and Opinion, 2023 
 2023Davis LL, Urganus A, Gagnon-Sanschagrin P, Maitland J, Qu W, Cloutier M, Guérin A, Aggarwal J 
- 
                                                        The Economic Burden of Posttraumatic Stress Disorder in the United States From a Societal PerspectiveThe Journal of Clinical Psychiatry, 2022 
 2022Davis LL, Schein J, Cloutier M, Gagnon-Sanschagrin P, Maitland J, Urganus A, Guerin A, Lefebvre P, Houle CR 
- 
                                                        Opioid-Induced Constipation: Cost Impact of Approved Medications in the Emergency DepartmentAdvances in Therapy, 2022 
 2022Peacock WF, Slatkin N, Gagnon-Sanschagrin P, Maitland J, Guérin A, Joseph G 
- 
                                                        Treatment patterns among children and adolescents with attention-deficit/hyperactivity disorder in the United States - a retrospective claims analysisBMC Psychiatry, 2022 
 2022Schein J, Childress A, Adams J, Gagnon-Sanschagrin P, Maitland J, Qu W, Cloutier M, Guérin A 
- 
                                                        Mental Health and Health-Related Quality of Life Among Nephrology Nurses: A Survey-Based Cross-Sectional StudyNephrology Nursing Journal, 2021 
 2021Montoya V, Donnini K, Gauthier-Loiselle M, Sanon M, Cloutier M, Maitland J, Guérin A, Dutka P, Pryor L, Thomas-Hawkins C, Voegel A, Hoffmann M, Savin S, Kurzman A, Kear T 
- 
                                                        Treatment patterns among adults with attention-deficit/hyperactivity disorder in the United States: a retrospective claims studyCurrent Medical Research and Opinion, 2021 
 2021Schein J, Childress A, Adams J, Cloutier M, Gagnon-Sanschagrin P, Maitland J, Bungay R, Guérin A, Lefebvre P 
- 
                                                        Regional variations in prevalence and severity of autosomal dominant polycystic kidney disease in the United StatesCurrent Medical Research and Opinion, 2021 
 2021Willey C, Gauthier-Loiselle M, Cloutier M, Shi S, Maitland J, Stellhorn R, Sanon Aigbogun M 
 
        